|4Feb 26, 8:25 AM ET

Caveney Brian J 4

4 · LABCORP HOLDINGS INC. · Filed Feb 26, 2026

Research Summary

AI-generated summary of this filing

Updated

LabCorp (LH) EVP Brian J. Caveney Sells 1,500 Shares

What Happened
Brian J. Caveney, EVP and President of Enterprise Diagnostics (also CMO & CSO) at LabCorp (LH), reported a sale of 1,500 shares on 2026-02-24. The shares were disposed at $286.31 per share, for a reported total of approximately $429,458. This was a sale (code S) rather than a purchase—sales are often routine and do not necessarily signal a change in investment conviction.

Key Details

  • Transaction date and price: 2026-02-24, 1,500 shares at $286.31 per share (reported total ≈ $429,458).
  • Transaction type: Reported as an open-market or private sale (code S).
  • Filing date: Form 4 filed 2026-02-26 (filed within the typical two-business-day window).
  • Shares owned after transaction: Not specified in the provided excerpt of the filing.
  • Footnotes/plan indicators: No 10b5-1 plan, tax withholding, or other special footnotes were noted in the provided transaction details.

Context
Sales by executives can be for many reasons (diversification, liquidity needs, tax planning) and are not by themselves a clear bullish or bearish signal. Purchases generally attract more attention from investors. This report documents the disposal; there’s no indication here of option exercise, gift, or other derivative activity.

Insider Transaction Report

Form 4
Period: 2026-02-24
Caveney Brian J
EVP, Pres of ED, CMO & CSO
Transactions
  • Sale

    Common Stock

    2026-02-24$286.31/sh1,500$429,45830,106.923 total
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney|2026-02-26

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT